TMPO expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.918200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.292200E-01
Normal-vs-Stage2
6.046400E-01
Normal-vs-Stage3
2.165400E-01
Normal-vs-Stage4
9.133800E-01
Stage1-vs-Stage2
9.093200E-01
Stage1-vs-Stage3
1.684000E-01
Stage1-vs-Stage4
3.481800E-01
Stage2-vs-Stage3
1.165770E-01
Stage2-vs-Stage4
4.670200E-01
Stage3-vs-Stage4
2.366600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.067400E-01
Normal-vs-AfricanAmerican
3.613400E-01
Normal-vs-Asian
1.807770E-01
Caucasian-vs-AfricanAmerican
7.050800E-01
Caucasian-vs-Asian
2.141600E-01
AfricanAmerican-vs-Asian
6.121800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.999800E-01
Normal-vs-Female
5.846200E-01
Male-vs-Female
8.159200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.794800E-01
Normal-vs-Age(41-60Yrs)
6.539800E-01
Normal-vs-Age(61-80Yrs)
5.688000E-01
Normal-vs-Age(81-100Yrs)
5.766000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.515200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.034400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.482800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.670800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.417400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.875400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.776000E-01
Normal-vs-Daily Drinker
3.387000E-01
Normal-vs-Weekly Drinker
4.834000E-01
Normal-vs-Occasional Drinker
5.986800E-01
Normal-vs-Social Drinker
3.069600E-01
Non Drinker-vs-Daily Drinker
9.317000E-01
Non Drinker-vs-Weekly Drinker
3.676400E-01
Non Drinker-vs-Occasional Drinker
3.927200E-01
Non Drinker-vs-Social Drinker
9.214800E-01
Daily Drinker-vs-Weekly Drinker
5.789600E-01
Daily Drinker-vs-Occasional Drinker
4.283400E-01
Daily Drinker-vs-Social Drinker
8.906000E-01
Weekly Drinker-vs-Occasional Drinker
1.983600E-01
Weekly Drinker-vs-Social Drinker
4.319200E-01
Occasional Drinker-vs-Social Drinker
5.051800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.580000E-01
Normal-vs-Grade 2
2.901800E-01
Normal-vs-Grade 3
2.757400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.122200E-01
Grade 1-vs-Grade 3
1.822640E-01
Grade 1-vs-Grade 4
4.580000E-01
Grade 2-vs-Grade 3
3.443200E-01
Grade 2-vs-Grade 4
2.901800E-01
Grade 3-vs-Grade 4
2.757400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.883200E-01
Normal-vs-NonDiabetic
5.555000E-01
Diabetic-vs-NonDiabetic
8.539800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.715200E-01
Normal-vs-NoPancreatitis
5.779000E-01
Pancreatitis-vs-NoPancreatitis
3.417000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.879200E-01
Normal-vs-N1
6.077000E-01
N0-vs-N1
7.787200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.440200E-01
Normal-vs-TP53-NonMutant
7.068000E-01
TP53-Mutant-vs-TP53-NonMutant
7.270600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
